Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 17, 2022
Mid-term results of Optimize PRO clinical study reinforces benefits of predictability and control using cusp overlap technique
-
May 2, 2022
EXPAND TAVR II Pivotal Trial evaluating the Evolut™ TAVR platform in a new patient population
-
Apr 4, 2022
ACC.22: Late-breaking data show CoreValve™ and Evolut™ is the only platform to out-perform surgery in valve durability at five years
